Autoproteolytic activation of bacterial toxins

Aimee Shen1

  • 1Department of Pathology, Stanford School of Medicine, 300 Pasteur Drive, Stanford, California, USA. ashen2@stanford.edu

Toxins
|November 10, 2011
PubMed

Insights

Bacterial toxins use cysteine protease domains (CPDs) to release effector domains, activated by inositol hexakisphosphate (InsP(6)). This regulation offers a target for developing novel anti-toxin therapies.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Microbiology

Background:

  • Protease domains in bacterial toxins usually function as effector domains.
  • Cysteine protease domains (CPDs) in MARTX and glucosylating toxins cleave the toxin to release effectors.
  • CPD activation is regulated by eukaryotic cytosol-abundant inositol hexakisphosphate (InsP(6)).

Purpose of the Study:

  • To review findings on CPD regulation of toxin function.
  • To explore the development of inhibitors targeting CPD-mediated toxin activation.
  • To highlight CPD as a target for anti-toxin therapeutics.

Main Methods:

  • Review of recent scientific literature.
  • Analysis of CPD structure and function.
  • Exploration of inhibitor development strategies.

Main Results:

  • CPDs play a regulatory role, distinct from direct effector function.
  • InsP(6) binding is crucial for CPD activation and toxin release.
  • CPD-mediated regulation allows spatial and temporal control of toxin activity.

Conclusions:

  • CPDs are key regulators of toxin activation in specific bacterial families.
  • The InsP(6)-dependent activation mechanism presents a unique therapeutic target.
  • Inhibiting CPDs offers a promising strategy for developing novel anti-toxin treatments.

Related Concept Videos

Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...